The main objective of the PROBIOPOL project is the development of methodologies and tools to support the design and management of sustainable processes for the production of biodegradable polyhydroxyalcanoates (PHAs) biopolymers. PHAs are linear polyesters produced in nature by bacteria through aerobic fermentation of many carbon sources, completely biodegradable and biocompatible. PROBIOPOL project will develop a new, cost effective and environmental sustainable technology for isolating PHAs from bacteria mixed cultures by combining: a) innovative cells' pre-treatments and polymer purification's strategy by means of TiO2/UV or Ag0 nanostructured materials; b) polymer extraction through a green and safe system directly applicable to bacterial cultures, which combines the advantages of solvent extraction and these of dissolution of the nonPHAs cellular matrix through surfactants; c) monitoring and control tools for process energy and efficiency management. T2.2 Development of lab-scale implant integrating novel bacteria pre and post treatments and automation tools, in particular focused on Design of a fully automated compact system for the production of pure PHA from wastes.
Fabbrica del Futuro ProBioPol D 2.2 - Specific characteristics of the demo plant
2014
Abstract
The main objective of the PROBIOPOL project is the development of methodologies and tools to support the design and management of sustainable processes for the production of biodegradable polyhydroxyalcanoates (PHAs) biopolymers. PHAs are linear polyesters produced in nature by bacteria through aerobic fermentation of many carbon sources, completely biodegradable and biocompatible. PROBIOPOL project will develop a new, cost effective and environmental sustainable technology for isolating PHAs from bacteria mixed cultures by combining: a) innovative cells' pre-treatments and polymer purification's strategy by means of TiO2/UV or Ag0 nanostructured materials; b) polymer extraction through a green and safe system directly applicable to bacterial cultures, which combines the advantages of solvent extraction and these of dissolution of the nonPHAs cellular matrix through surfactants; c) monitoring and control tools for process energy and efficiency management. T2.2 Development of lab-scale implant integrating novel bacteria pre and post treatments and automation tools, in particular focused on Design of a fully automated compact system for the production of pure PHA from wastes.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
